Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted June 14, 2013
Weight Loss Supplement Found To Contain Undeclared Drug
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.
XIYOUJI QINGZHI CAPSULE was sold on various websites, including www.jadera.net.
Consumers who have purchased this supplement should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA’s MedWatch Adverse Event Reporting Program.
See ConsumerLab.com’s Review of Weight Loss Supplements for tests of related products.
See Related Warnings:
To read the FDA’s warning, use the link below.